Fayez Sarofim & Co

Position in HALO — Halozyme Therapeutics, Inc.

CIK 937729 Houston, TX

Position in HALO

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$587,025

+$102,300 QoQ

Shares Held

7,500

0.0% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#367

of 664 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Fayez Sarofim & Co holds $7,172,383 across 4 Biotechnology names. HALO ranks #3 (8.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	10,000	$4,967,300
2	REGN	Regeneron Pharmaceuticals, Inc.	2,460	$1,533,908
3	HALO	Halozyme Therapeutics, Inc. This page	7,500	$587,025
4	NAUT	Nautilus Biotechnology, Inc.	45,000	$84,150

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$587,025	7,500	0.0%	Shares	Defined	2026-08-17
2026-03-31	$484,725	7,500	0.0%	Shares	Defined	2026-05-15
2025-12-31	$504,750	7,500	0.0%	Shares	Defined	2026-02-13
2025-09-30	$550,050	7,500	0.0%	Shares	Defined	2025-11-14
2025-06-30	$390,150	7,500	0.0%	Shares	Defined	2025-08-14
2025-03-31	$478,575	7,500	0.0%	Shares	Defined	2025-05-12
2024-12-31	$358,575	7,500	—	Shares	Defined	2025-02-14
No filing history on record for this holder in this stock.